GraniteShares Advisors LLC Sells 429 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

GraniteShares Advisors LLC decreased its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 13.2% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,821 shares of the medical equipment provider’s stock after selling 429 shares during the period. GraniteShares Advisors LLC’s holdings in Intuitive Surgical were worth $1,472,000 at the end of the most recent reporting period.

A number of other hedge funds also recently bought and sold shares of the company. Lake Street Advisors Group LLC boosted its stake in Intuitive Surgical by 6.0% in the 4th quarter. Lake Street Advisors Group LLC now owns 3,473 shares of the medical equipment provider’s stock worth $1,813,000 after purchasing an additional 197 shares in the last quarter. JFG Wealth Management LLC bought a new position in Intuitive Surgical in the 4th quarter worth about $1,162,000. Kirtland Hills Capital Management LLC boosted its stake in Intuitive Surgical by 15.0% in the 4th quarter. Kirtland Hills Capital Management LLC now owns 1,125 shares of the medical equipment provider’s stock worth $587,000 after purchasing an additional 147 shares in the last quarter. Longbow Finance SA bought a new position in Intuitive Surgical in the 4th quarter worth about $4,431,000. Finally, Amalgamated Bank boosted its stake in Intuitive Surgical by 2.1% in the 4th quarter. Amalgamated Bank now owns 78,171 shares of the medical equipment provider’s stock worth $40,802,000 after purchasing an additional 1,592 shares in the last quarter. Institutional investors own 83.64% of the company’s stock.

Insiders Place Their Bets

In other Intuitive Surgical news, CFO Jamie Samath sold 188 shares of the company’s stock in a transaction that occurred on Friday, November 29th. The stock was sold at an average price of $539.00, for a total value of $101,332.00. Following the completion of the transaction, the chief financial officer now directly owns 8,757 shares in the company, valued at $4,720,023. This represents a 2.10 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, EVP Myriam Curet sold 408 shares of the company’s stock in a transaction that occurred on Tuesday, February 11th. The stock was sold at an average price of $589.75, for a total value of $240,618.00. Following the completion of the transaction, the executive vice president now owns 353 shares of the company’s stock, valued at $208,181.75. The trade was a 53.61 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 6,240 shares of company stock worth $3,529,040 in the last three months. 0.80% of the stock is owned by company insiders.

Intuitive Surgical Trading Down 2.9 %

Intuitive Surgical stock opened at $573.74 on Wednesday. Intuitive Surgical, Inc. has a 12-month low of $364.17 and a 12-month high of $616.00. The firm has a market capitalization of $204.35 billion, a price-to-earnings ratio of 89.51, a P/E/G ratio of 5.85 and a beta of 1.39. The firm has a 50 day moving average of $567.01 and a 200 day moving average of $527.27.

Analysts Set New Price Targets

A number of equities analysts recently issued reports on ISRG shares. Wells Fargo & Company upped their price target on shares of Intuitive Surgical from $630.00 to $687.00 and gave the stock an “overweight” rating in a research note on Friday, January 24th. JPMorgan Chase & Co. boosted their target price on Intuitive Surgical from $575.00 to $675.00 and gave the stock an “overweight” rating in a research report on Friday, January 24th. Leerink Partners boosted their target price on Intuitive Surgical from $490.00 to $548.00 in a research report on Monday, January 27th. Citigroup boosted their target price on Intuitive Surgical from $640.00 to $711.00 and gave the stock a “buy” rating in a research report on Friday, January 24th. Finally, Stifel Nicolaus boosted their target price on Intuitive Surgical from $525.00 to $610.00 and gave the stock a “buy” rating in a research report on Thursday, December 5th. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and sixteen have given a buy rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $613.10.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.